| Efficacy Study of Ilaprazole to Treat Erosive Esophgitis (NCT01509261) | Il-Yang Pharm. Co., Ltd. | 2010-07-01 |
| Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease. (NCT01601379) | Janssen-Cilag International NV | 2010-06-01 |
| An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease (NCT01134367) | AstraZeneca | 2010-05-01 |
| Observational Study of Anti-Reflux Surgery (NCT01624506) | Torax Medical Incorporated | 2010-01-01 |
| Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study (NCT01574573) | Midwest Biomedical Research | 2009-06-01 |
| A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1 (NCT01384695) | Anandasabapathy, Sharmila, M.D. | 2009-06-01 |
| Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy (NCT01386255) | Boston Children's Hospital | 2009-04-01 |
| Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD (NCT00624546) | University of Rochester | 2009-01-01 |
| Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy (NCT01710800) | Walter Reed National Military Medical Center | 2008-09-01 |
| Domperidone for Relief of Gastrointestinal Disorders (NCT00761254) | Carle Physician Group | 2008-08-01 |
| Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance (NCT01079884) | David A. Johnson, MD | 2008-07-01 |
| The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis (NCT00728481) | Mayo Clinic | 2008-05-01 |
| Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms (NCT00703534) | AstraZeneca | 2008-05-01 |
| A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive (NCT00747695) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-03-01 |
| Does Omeprazole Decrease Intestinal Calcium Absorption? (NCT00582972) | University of Wisconsin, Madison | 2008-01-01 |
| National Survey on Gastroesophageal Reflux Disease (GERD) Patients (NCT00695838) | AstraZeneca | 2008-01-01 |
| Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD (NCT00634023) | AstraZeneca | 2008-01-01 |
| Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis (NCT00586963) | Mayo Clinic | 2008-01-01 |
| Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study (NCT00697008) | AstraZeneca | 2007-12-01 |
| Study of Endoscopic Barrett's Esophagus Diagnosis (NCT00591461) | Oregon Health and Science University | 2007-12-01 |
| Minimally Invasive Surgery of the Gastro-esophageal Junction (NCT01799967) | Ottawa Hospital Research Institute | 2007-11-01 |
| What is the Predictive Value of the Reflux Impact Scale (NCT00536328) | AstraZeneca | 2007-10-01 |
| Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus (NCT00573911) | Mayo Clinic | 2007-08-01 |
| LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS) (NCT00567619) | AstraZeneca | 2007-07-01 |
| Barrett's Esophagus & Gastroesophageal Reflux Disease (NCT00513331) | Valley Health System | 2007-07-01 |
| Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD (NCT00524355) | AstraZeneca | 2007-03-01 |
| Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients (NCT00444275) | AstraZeneca | 2007-03-01 |
| Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use (NCT00691171) | AstraZeneca | 2007-01-01 |
| Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease (NCT00388453) | Vanderbilt University Medical Center | 2006-10-01 |
| Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD) (NCT00373334) | Braintree Laboratories | 2006-08-01 |
| Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343) (NCT00336219) | Takeda | 2006-08-01 |
| Impact of GERD on Daily Life (NIS) (NCT00545883) | AstraZeneca | 2006-06-01 |
| Effect of Coffee on Gastro-Esophageal Disease in Patients With Symptoms of Reflux (NCT00584259) | University of California, Davis | 2006-05-01 |
| to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD (NCT00324532) | BioBalance Corporation | 2006-05-01 |
| Nexium RESPONSE Trial (NCT00318968) | AstraZeneca | 2006-05-01 |
| Multi-Center Study of the NDO Surgical Plicator Utilizing Multiple Implants for the Treatment of GERD (NCT00586859) | NDO Surgical, Inc. | 2006-05-01 |
| A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes (NCT00681005) | National Taiwan University Hospital | 2006-04-01 |
| Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer (NCT00321958) | University of Maryland, Baltimore | 2006-04-01 |
| Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma (NCT00317044) | AstraZeneca | 2006-04-01 |
| Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD (NCT00295685) | Digestive & Liver Disease Specialists | 2005-10-01 |
| A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease (NCT00838396) | Indivior Inc. | 2005-10-01 |
| A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole (NCT00378287) | Janssen-Ortho Inc., Canada | 2005-10-01 |
| The Utility of Nexium in Chronic Cough and Reflux Disease (NCT00287339) | University of North Carolina, Chapel Hill | 2005-09-01 |
| Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506) (NCT00261339) | Takeda | 2005-08-01 |
| CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing (NCT00354757) | National Taiwan University Hospital | 2005-06-01 |
| Conventional Nissen Fundoplication Versus Laparoscopic Nissen Fundoplication (NCT01230944) | Turku University Hospital | 2004-12-01 |
| Sleep Disorders and Gastroesophageal Reflux Disease (GERD) (NCT00287391) | University of North Carolina | 2004-09-01 |
| Registry Study of the NDO Surgical Plicator for the Treatment of GERD (NCT00597792) | NDO Surgical, Inc. | 2004-08-01 |
| The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients (NCT00524251) | AstraZeneca | 2004-06-01 |
| On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication (NCT00161096) | UMC Utrecht | 2004-03-01 |
| PPI Versus Placebo in Severe Functional Heartburn (NCT00222989) | University of Southern California | 2003-10-01 |
| PPI Test in GP Patients (NCT00318084) | AstraZeneca | 2003-01-01 |
| Comparison of Laparoscopic Hill and Laparoscopic Nissen Anti-Reflux Procedures (NCT01260935) | Swedish Medical Center | 2002-11-01 |
| An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) (NCT00629564) | AstraZeneca | 2002-09-01 |
| Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously (NCT00635414) | AstraZeneca | 2002-08-01 |
| Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs (NCT00241514) | AstraZeneca | 2001-02-01 |
| Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs (NCT00241540) | AstraZeneca | 2001-01-01 |
| Surgery in Chronic Cough GERD Related (NCT01899183) | University of Bologna | 1995-01-01 |
| Gatekeeper European 005 (NCT00229086) | MedtronicNeuro | |
| Treatment Use of Domperidone for Gastroparesis (NCT02227927) | Scott Gabbard, MD | |